Intrastromal femtosecond laser presbyopia correction successful

Article

Using the intrastromal femtosecond laser procedure to correct presbyopia has been shown to be successful.

Using the intrastromal femtosecond laser procedure to correct presbyopia has been shown to be successful, in a recent study published in the Journal of Refractive Surgery.

The prospective multicentre, nonrandomized clinical investigation, headed by Dr Mike P. Holzner, Department of Ophthalmology, International Vision Correction Research Centre, University of Heidelberg, Germany, included 63 presbyopic patients with mild hyperopia.

The procedure was performed using a femtosecond laser in the non-dominant eye and conducting near and distance visual acuity tests, slit-lamp examinations, and corneal topography. Follow-up was completed at 1 day, 1 week, and 1, 3, 6, and 12 months post-op for each patient.

Median uncorrected distance visual acuity and corrected distance visual acuity (CDVA) remained stable at 0.1 logMAR and 0.0 logMAR, respectively. Median spherical equivalent changed from +0.63 D before surgery to 0.00 D after surgery.

Preoperatively, median uncorrected near visual acuity was 0.7 logMAR but increased to 0.2 logMAR postoperatively. Eyes gained an average of 4 lines, but a loss of 2 lines of CDVA was seen in 7.1% of eyes.

The procedure demonstrated stable visual outcomes over a one year follow-up. Patient satisfaction was very high at 80%, with short treatment time and corneal surface integrity being major benefits of the procedure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.